CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Private Placement	Registered Direct Offering	Common stock	Common stock Private Placement	Common stock Registered Direct Offering	Additional paid in capital	Additional paid in capital Private Placement	Additional paid in capital Registered Direct Offering	Treasury stock	Accumulated deficit
Beginning balance, common shares (in shares) at Dec. 31, 2022				127,022,363
Beginning balance at Dec. 31, 2022	$ (37,872)			$ 14			$ 272,528			$ (57,350)	$ (253,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(43,109)										(43,109)
Equity-based compensation expense	7,799						7,799
Issuance of Private Placement shares/Registered Direct Offering shares (in shares)					13,888,889	11,848,341
Issuance of Private Placement shares/Registered Direct Offering shares		$ 7,081	$ 6,765		$ 2	$ 1		$ 7,079	$ 6,764
Issuance of shares for equity-based compensation awards, net (in shares)				1,984,523
Issuance of shares for equity-based compensation awards, net	(2,237)						(2,237)
Issuance of shares for exercised convertible notes (in shares)				188
Issuance of shares purchased under ESPP (in shares)				708,470
Ending balance, common shares (in shares) at Jun. 30, 2023				155,452,774
Ending balance at Jun. 30, 2023	(61,573)			$ 17			291,933			(57,350)	(296,173)
Beginning balance, common shares (in shares) at Mar. 31, 2023				141,823,207
Beginning balance at Mar. 31, 2023	(54,039)			$ 16			282,573			(57,350)	(279,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(16,895)										(16,895)
Equity-based compensation expense	3,994						3,994
Issuance of Private Placement shares/Registered Direct Offering shares (in shares)						11,848,341
Issuance of Private Placement shares/Registered Direct Offering shares			$ 6,765			$ 1			$ 6,764
Issuance of shares for equity-based compensation awards, net (in shares)				1,072,662
Issuance of shares for equity-based compensation awards, net	(1,398)						(1,398)
Issuance of shares for exercised convertible notes (in shares)				94
Issuance of shares purchased under ESPP (in shares)				708,470
Ending balance, common shares (in shares) at Jun. 30, 2023				155,452,774
Ending balance at Jun. 30, 2023	$ (61,573)			$ 17			291,933			(57,350)	(296,173)
Beginning balance, common shares (in shares) at Dec. 31, 2023	157,287,522			157,287,522
Beginning balance at Dec. 31, 2023	$ (67,335)			$ 17			303,428			(57,350)	(313,430)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(136,884)										(136,884)
Equity-based compensation expense	$ 10,906						10,906
Exercise of options (in shares)	87,324			87,324
Exercise of options	$ 119						119
Issuance of common shares as consideration for the acquisition of Pangiam (in shares)				61,838,072
Issuance of common shares as consideration for the acquisition of Pangiam	207,776			$ 6			207,770
Proceeds from exercise of 2023 warrants (in shares)				22,775,144
Proceeds from exercise of 2023 warrants	90,707			$ 2			90,705
Issuance of shares for equity-based compensation awards, net (in shares)				4,311,703
Issuance of shares for equity-based compensation awards, net	(3,140)						(3,140)
Issuance of shares for exercised convertible notes (in shares)				94
Issuance of shares purchased under ESPP (in shares)				474,325
Issuance of shares purchased under ESPP	$ 607						607
Ending balance, common shares (in shares) at Jun. 30, 2024	246,774,184			246,774,184
Ending balance at Jun. 30, 2024	$ 102,756			$ 25			610,395			(57,350)	(450,314)
Beginning balance, common shares (in shares) at Mar. 31, 2024				246,061,379
Beginning balance at Mar. 31, 2024	108,482			$ 25			604,384			(57,350)	(438,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(11,737)										(11,737)
Equity-based compensation expense	5,749						5,749
Exercise of options (in shares)				22,780
Exercise of options	33						33
Issuance of shares for equity-based compensation awards, net (in shares)				215,700
Issuance of shares for equity-based compensation awards, net	(378)						(378)
Issuance of shares purchased under ESPP (in shares)				474,325
Issuance of shares purchased under ESPP	$ 607						607
Ending balance, common shares (in shares) at Jun. 30, 2024	246,774,184			246,774,184
Ending balance at Jun. 30, 2024	$ 102,756			$ 25			$ 610,395			$ (57,350)	$ (450,314)